Moreover, mice with CIA received the treatment with CXCR7 inhibitor, CCX733, significantly reduced the arthritis scores and the numbers of vessels in the synovial tissues, suggesting CXCR7 is potential target for novel RA antiangiogenic therapy. Here, ACKR3 is linked to arthritic joint disease.